期刊文献+

沉默调节蛋白6在肝脏疾病中的作用及其机制

Role and mechanism of SIRT6 in liver diseases
下载PDF
导出
摘要 沉默调节蛋白6(SIRT6)具有去乙酰化酶、单ADP核糖基转移酶以及去脂肪酰化酶等多种功能,在调控多种生理及病理过程中发挥重要作用。概述了SIRT6的结构及生物学功能,详细介绍了SIRT6在病毒性肝炎、非酒精性脂肪性肝病、酒精性脂肪性肝病、肝硬化、肝癌等不同类型的肝脏疾病中的研究进展及相关作用分子机制。了解SIRT6在肝脏疾病中的作用,可能为肝病的治疗提供新思路及治疗靶点。 SIRT6 has the multiple functions of deacetylase,single ADP ribosyltransferase,and defatty acylase and plays an important role in the regulation of various physiological and pathological processes.This article summarizes the structure and biological functions of SIRT6 and introduces in detail the research advances in the role and molecular mechanisms of SIRT6 in different types of liver diseases such as viral hepatitis,nonalcoholic fatty liver,alcoholic fatty liver,liver cirrhosis,and liver cancer.An understanding of the role of SIRT6 in liver diseases may provide new ideas and targets for the treatment of liver diseases.
作者 方欢 钟晓琳 FANG Huan;ZHONG Xiaolin(School of Clinical Medicine,Southwest Medical University,Luzhou,Sichuan 646000,China;Department of Gastroenterology,The Affiliated Hospital of Southwest Medical University,Luzhou,Sichuan 646000,China)
出处 《临床肝胆病杂志》 CAS 北大核心 2021年第8期1975-1978,共4页 Journal of Clinical Hepatology
基金 四川省科技厅基金项目(2020YJ0190) 王宝恩肝纤维化研究基金项目(20200520)。
关键词 乙型肝炎 慢性 非酒精性脂肪性肝病 肝硬化 肝细胞 抗衰老酶 Hepatitis B,Chronic Non-Alcoholic Fatty Liver Disease Liver Cirrhosis Carcinoma,Hepatocellular Sirtuins
  • 相关文献

参考文献8

二级参考文献149

  • 1Yan-Yan Ma,Lin Li,Chao-Hui Yu,Zhe Shen,Li-Hua Chen,You-Ming Li.Effects of probiotics on nonalcoholic fatty liver disease:A meta-analysis[J].World Journal of Gastroenterology,2013,19(40):6911-6918. 被引量:34
  • 2皮斌,田德英.过氧化物酶体增殖物活化受体与乙型肝炎病毒的复制及肝纤维化的关系[J].中华肝脏病杂志,2004,12(10):636-638. 被引量:1
  • 3吕艳秋,石刚刚.反义寡核苷酸技术研究进展[J].广东医学,2006,27(8):1270-1272. 被引量:13
  • 4Yang J, Bo X C, Wang S Q, et al. Antisense oligonucleiotides targeted against ASGPR1 block human hepatitis B virus replication[J]. J Viral Hepatitis, 2006,13(3):158-165. 被引量:1
  • 5Schorr O, Borel C, Trepo C, et al. Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytes[J]. J Hepatol, 2006,44(5):842-847. 被引量:1
  • 6Banks K E, Anderson A L, Tang H, et al. Hepatocyte nuclear factor 3 beta inhibits hepatitis B virus replication in vivo[J]. J Virol, 2002,76(24):12974-12980. 被引量:1
  • 7Tokusumi Y, Zhou S, Takada S. Nuclear respiratory factor 1 plays anessential role in transcriptional initiation from the hepatitis B virus xgene promoter [J]. J Virol, 2004,78(20): 108562-108564. 被引量:1
  • 8Chou Y C, Chen M L, Hu C P, et al. Transforming growth factor2 betal suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA[J]. Hepatology, 2007,46(3):672-681. 被引量:1
  • 9Braissant O, Foufelle F, Scotto C, et al. Differential expression of peroxisome p roliferator activated receptors (PPARs): tissue distribution of PPAR-alpha, beta, and gamma in the adult rat [J]. Endocrinology, 1996,137(1):354-366. 被引量:1
  • 10Raney A K, Kline E F, Tang H, et al. Transcription and replication of a natural hepatitis B virus nucleocapsid promoter variant is regulated in vivo by peroxisome proliferators[J]. Virology, 2001,289:239-251. 被引量:1

共引文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部